Center Laboratories, Inc. (TPEX: 4123)
Health Care · Pharmaceuticals · TW
NT$32.95
+1.70% today · -4.2% 1Y
Center Laboratories, Inc. (TPEX: 4123) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $811.04M and employs 182 people.
Over the last twelve months the share price has lost 4.2%, trading between 31.53 and 48.96.
Tweenvest scores Center Laboratories, Inc. across four factors: quality 46/100, value 45/100, growth 68/100, dividend 46/100. Its strongest factor is growth.
4123 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $811.04M
- Revenue (TTM)
- $52.07M
- P/E
- 25.63
- EPS
- 1.29
- Dividend yield
- 5.05%
- Beta (5Y)
- 0.29
- 52-week high
- NT$48.96
- 52-week low
- NT$31.53
- Avg volume (3M)
- —
- Shares outstanding
- 783.79M
- Employees
- 182
- Next earnings
- —
About Center Laboratories, Inc.
Center Laboratories, Inc. operates as a Taiwanese pharmaceutical enterprise, with its primary focus lying in the manufacturing and distribution of various medical products across Taiwan. Beyond its core drug operations, the firm is heavily invested in the research and development of both small molecule therapeutics and biologics, including proteins and antibodies. Additionally, its extensive portfolio encompasses pharmaceutical CDMO services, medical devices, nutritional health products, agribiotechnology initiatives, advanced stem cell and immune cell therapies, and even strategic ventures in industry investment funds and venture capital. Founded in 1959, Center Laboratories maintains its headquarters in Taipei, Taiwan.
- ISIN
- TW0004123005
- Founded
- 1959
- Listed since
- Dec 31, 2007
- Exchange
- Taipei Exchange
- Currency
- TWD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,233.66 | -1.06% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $273.14 | +0.04% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $156.45 | +3.84% |
| Roche Holding AGSWX: ROP | $371.62B | CHF373.80 | +0.92% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £124.76 | +3.02% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.57 | +2.15% |
Figures last refreshed Aug 18, 2026.